ConTiPi Medical

ConTIPI Medical Ltd. specializes in developing innovative, disposable devices for the non-invasive management of Pelvic Organ Prolapse (POP). The company targets women suffering from POP who prefer a non-surgical solution that can be managed independently at home. Operating in the medical device market, ConTIPI's business model revolves around the design, development, and sale of these unique medical devices. Revenue is generated through direct sales and partnerships with healthcare providers. The company's flagship products, such as the ProVate and Impressa devices, offer vaginal support and are designed for easy insertion and removal by the user, addressing the high discontinuation rates associated with traditional pessaries. ConTIPI leverages its in-house expertise in medical research, regulatory affairs, and clinical studies to maintain a competitive edge. The company's strong intellectual property portfolio and internal R&D capabilities further support its market position.

Keywords: Pelvic Organ Prolapse, non-invasive, disposable devices, vaginal support, home use, urogynecology, medical innovation, clinical studies, intellectual property, healthcare partnerships.